Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome

摘要: Patients with adult respiratory distress syndrome (ARDS) are highly heterogeneous but current therapies rather uniform and largely supportive. In the previous issue of Critical Care, Clark colleagues report that biomarker GDF-15 provides prognostic information in ARDS is additive to provided by APACHE III score. high levels growth-differentiation factor 15 (GDF-15) had a higher mortality more complicated hospital course. Biomarkers such as may help us identify patients at risk who eventually benefit from personalized targeted therapies.